Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Originalsprog	Engelsk
Tidsskrift	Journal of Pharmacology and Experimental Therapeutics
Vol/bind	317
Udgave nummer	2
Sider (fra-til)	910-918
Antal sider	9
ISSN	0022-3565
DOI	https://doi.org/10.1124/jpet.105.097006
Status	Udgivet - 2006
Eksternt udgivet	Ja

ID: 146293280